Mardis Elaine R 4
4 · Singular Genomics Systems, Inc. · Filed Jan 6, 2022
Insider Transaction Report
Form 4
Mardis Elaine R
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-01-05+40,000→ 40,000 totalExercise: $9.07Exp: 2032-01-05→ Common Stock (40,000 underlying)
Footnotes (1)
- [F1]1/3rd of the option shares vest and become exercisable on January 5, 2023 with the remaining option shares vesting in 24 equal monthly installments thereafter.